Intellia Jumps After Gene-Editing Therapy Succeeds in Pivotal Trial for Rare Swelling Disorder
Intellia Therapeutics rose sharply after reporting successful late-stage results for its experimental gene-editing treatment for hereditary angioedema, a rare disorder that causes dangerous and recurring swelling attacks. The company’s therapy met the main goal of its pivotal trial, helping drive shares higher. The treatment is important because it represents a major step forward for in […]
Stronger-Than-Expected Tesla Results Come With a Bigger Bet on Robots, AI and Future Growth
Tesla reported first-quarter results that beat Wall Street expectations and used the moment to signal an even bigger long-term investment push. The company said it now expects capital expenditures in 2026 to exceed $25 billion, a sharp increase from both last year’s spending and its earlier forecast of around $20 billion. This would amount to […]
Moderna Begins Late-Stage Bird Flu Vaccine Trial in U.S. and U.K.
Moderna has begun a late-stage clinical trial of its experimental bird flu vaccine in the United States and the United Kingdom, marking a significant milestone in the effort to prepare for a possible future influenza pandemic. This is the first pandemic bird flu vaccine built with mRNA technology to reach a late-stage trial, moving the […]
Blue Owl Expands Healthcare Real Estate Bet With $2.4 Billion Deal for Sila Realty Trust
Blue Owl Capital has agreed to acquire Sila Realty Trust in an all-cash deal valued at about $2.4 billion, expanding its push into healthcare real estate at a time when alternative asset managers are looking for steadier, income-producing assets.The acquisition will be made through Blue Owl’s real assets division and includes Sila’s portfolio of 137 […]
U.S. Companies Flood New Refund System After Court Orders Return of Illegally Collected Tariffs
A new federal refund system has gone live to let U.S. companies recover money paid under tariffs that were later ruled illegal, triggering a rush of claims from importers eager to reclaim billions of dollars. The portal was launched by U.S. Customs and Border Protection after a court order required the government to prepare to […]
U.S. Factory Output Slips in March as Manufacturing Auto Production Weakens
U.S. manufacturing output declined in March, adding to evidence that the factory sector may be losing momentum after a period of resilience. Apparently, manufacturing production fell 0.3% in March after an upwardly revised 0.9% increase in February. The data suggests that while factories had shown some ability to keep growing earlier in the year, that […]
Uldouz Wallace’s PROTECT Act Advances in Arizona as U.S. and Global Adoption Accelerates
Arizona’s PROTECT Act, introduced by Arizona State Representative Nick Kupper following outreach from Uldouz Wallace, is advancing toward final approval, marking a critical step in addressing the growing global crisis of online exploitation, non-consensual content, and AI-generated deepfake abuse. The legislation has already passed out of the Arizona State House with a bipartisan supermajority and […]
Lilly’s New Obesity Pill Wins Approval, but FDA Demands Extra Studies on Liver and Heart Risks
Eli Lilly’s newly approved weight-loss pill has cleared an important regulatory hurdle, but the U.S. Food and Drug Administration is requiring the company to carry out additional safety studies after launch, showing that regulators still want closer scrutiny of the medicine’s risks. Apparently, FDA asked Lilly for more data on possible liver injury linked to […]
Amazon Buys Globalstar in $11.57 Billion Deal to Strengthen Its Satellite Push Against Starlink
Amazon has agreed to acquire satellite company Globalstar in an $11.57 billion deal, a major move that strengthens its effort to challenge Elon Musk’s Starlink in the fast-growing market for satellite-based connectivity. The acquisition gives Amazon control of Globalstar’s direct-to-device satellite technology and adds its existing two dozen satellites to Amazon’s broader low-Earth-orbit network, which […]
Earnings Season Will Test Whether Strong Profits Can Keep Wall Street Steady Despite War Risks
Wall Street is heading into a critical first-quarter earnings season that may determine whether the stock market can stay resilient despite the economic risks created by the war involving Iran. Investors are looking for proof that strong corporate profits can continue to support U.S. equities even as higher energy prices and geopolitical uncertainty threaten to […]
